摘要
目的了解现代电休克治疗(MECT)的临床治疗情况。方法对在2004年11月～2005年12月住我院期间,符合CCMD-3诊断标准诊断为精神分裂症的123例患者,其中58例应用MECT联合抗精神病药物治疗设为研究组,65例为单纯应用抗精神病药物治疗者为对照组(研究组中1例因家属拒绝治疗中途脱落)。经8周治疗在治疗前、治疗后的1、2、4、8周应用简明精神病量表(BPRS)评定疗效,在8周后做副反应量表(TESS)评定不良反应。结果在第2周、第4周末BPRS评分研究组明显低于对照组,有统计学差异,治疗前及第1周、第8周末两组无统计学差异,而TESS的评定,对照组比研究组的发生率高,有统计学差异。结论MECT联合抗精神病药物治疗比单纯抗精神病药物治疗起效快、安全性高,可在临床上广泛使用。
Objective To investigation MECT＇s using in clinical therapy. Methods 123 inpatients who met CCMD-3 diagnostic criteria for schizophrenia were studied from November, 2004 to December, 2005. 58 patients were treated using MECT and antipsychotic as studying group （1 case was dropped out because of going home during trial）, 65 patients only using antipsychotic as controlling group. All patients were assessed using BPRS in pre-treatment, post-treatment 1, 2, 4 and 8 week, and assessed using TESS after 8 week. Results The score of BPRS of studying group was significant lower than those of controlling group in end of 2 and 4 weeks, and there were no significant difference in pre-therapy and post 8 weeks. The occurrence rate of TESS was higher in controlling group than in studying group. Conclusion There was faster and safer using MECT and antipsychotic than using antipsychotic in treatment of schizophrenia.
出处
《中国健康心理学杂志》
2007年第5期427-428,共2页
China Journal of Health Psychology
